An ongoing Oxford University research could transform cancer treatment within a decade.
Scientists are developing a vaccine to fight different types of cancer, similar to the successful prevention of measles and mumps, according to media reports.
The study supported by the NHS, Cancer Research UK, the Spain-based CRIS Cancer Foundation and other popular pharmaceutical companies, has the potential to prevent cancer.
It is expected to save nearly 3.6 million patients across the globe annually with improved lifespan.
The clinical trial of a lung cancer vaccine will take place next year, followed by vaccines in progress for other cancers like breast, ovarian and bowel.
The study aims to combine these vaccines into one free anti-cancer injection administered to people during their NHS GP visits.
The development also allows more resources to tackle other severe health concerns like dementia or heart diseases.
